Sales & Marketing pharmaphorum returns as FH24 media partner pharmaphorum is pleased to announce its renewed role as a media partner for the upcoming Frontiers Health 2024 conference.
News United's PAH drug clears phase 3 trial, setting up filings United Therapeutics will file ralinepag as a treatment for pulmonary arterial hypertension later this year, but can it compete in a crowded market?
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
